Agios Pharmaceuticals Inc (AGIO) स्टॉकची किंमत आणि बातम्या

मुख्यपृष्ठAGIO • NASDAQ

Agios Pharmaceuticals Inc

$२६.५३

२१ जाने, १:३२:११ PM [GMT]-५ · USD · NASDAQ · डिस्क्लेमर

स्टॉकयूएस वरील सूचीबद्ध स्टॉक

याआधी बंद झाले

$२६.६८

आजची रेंज

$२६.४२ - $२७.१३

वर्षाची रेंज

$२२.२४ - $४५.९९

बाजारातील भांडवल

१.५५ अब्ज USD

सरासरी प्रमाण

१३.९२ लाख

P/E गुणोत्तर

लाभांश उत्पन्न

प्राथमिक एक्सचेंज

NASDAQ

बाजारपेठेच्या बातम्या

MarketBeat

१२ मिनिटांपूर्वी

Simmons First National (NASDAQ:SFNC) Trading 7.1% Higher After Strong Earnings

Dow Jones Today: DJIA Gains as Trump Rules Out Using Force Against Greenland; Global Leaders Converge for WEF

Stock market today: Dow, S&P 500, Nasdaq futures slip after brutal sell-off in wait for Trump's Davos speech

Trump in Davos says NATO should allow the US to take Greenland but he won’t use force

Fortune

४ तासांपूर्वी

The NYSE's big tokenization plan is nothing but vaporware a says Columbia business professor

MarketWatch

१ तासापूर्वी

Dow heads for best day in roughly two weeks after Trump's Davos speech

.DJI

०.६५%

बद्दल

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia

स्थापना केल्याची तारीख

२००८

वेबसाइट

agios.com

कर्मचारी

४८७